{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:59:29Z","timestamp":1784829569446,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jaci.2024.07.018","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T07:00:33Z","timestamp":1722322833000},"page":"1325-1332.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["TH2 cell compensatory effect following benralizumab treatment for eosinophilic gastritis"],"prefix":"10.1016","volume":"154","author":[{"given":"Netali","family":"Ben-Baruch Morgenstern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yrina","family":"Rochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret H.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent A.","family":"Mukkada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Putnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara L.","family":"Kliewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9790-6332","authenticated-orcid":false,"given":"Marc E.","family":"Rothenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.07.018_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaci.2003.10.047","article-title":"Eosinophilic gastrointestinal disorders (EGID)","volume":"113","author":"Rothenberg","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.07.018_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaci.2023.01.021","article-title":"Local type 2 immunity in eosinophilic gastritis","volume":"152","author":"Ben-Baruch Morgenstern","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.07.018_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.gastro.2017.06.065","article-title":"Pathophysiology of eosinophilic esophagitis","volume":"154","author":"O'Shea","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2024.07.018_bib4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1164\/rccm.201103-0396OC","article-title":"Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study","volume":"184","author":"Castro","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.07.018_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S2468-1253(23)00145-0","article-title":"Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"8","author":"Kliewer","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2024.07.018_bib7","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/PAS.0000000000001667","article-title":"Lymphocytic esophagitis: current understanding and controversy","volume":"46","author":"Pittman","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2024.07.018_bib8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mi.2015.2","article-title":"Eosinophils in mucosal immune responses","volume":"8","author":"Travers","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2024.07.018_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/cei\/uxac038","article-title":"The regulatory role of eosinophils in viral, bacterial, and fungal infections","volume":"209","author":"Gaur","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2024.07.018_bib10","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2014.07.026","article-title":"Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome","volume":"134","author":"Caldwell","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.07.018_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0091-6749(97)70255-0","article-title":"Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses","volume":"100","author":"Braun","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.07.018_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fmed.2017.00261","article-title":"Eosinophilic gastrointestinal disorders pathology","volume":"4","author":"Collins","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2024.07.018_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2019.11.007","article-title":"Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: multi-site study","volume":"145","author":"Shoda","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.07.018_bib14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.immuni.2015.02.004","article-title":"Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs\u00a0oral tolerance and promotes food allergy","volume":"42","author":"Noval Rivas","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2024.07.018_bib15","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.4049\/jimmunol.1101283","article-title":"Hierarchical IL-5 expression defines a subpopulation of highly differentiated human Th2 cells","volume":"187","author":"Upadhyaya","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2024.07.018_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam9171","article-title":"A phenotypically and functionally distinct human T(H)2 cell subpopulation is associated with allergic disorders","volume":"9","author":"Wambre","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2024.07.018_bib17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/cea.14152","article-title":"Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitis","volume":"52","author":"Walter","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.07.018_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1074-7613(03)00179-1","article-title":"Regulation of the Th2 cytokine locus by a locus control region","volume":"19","author":"Lee","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2024.07.018_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fmed.2018.00049","article-title":"Targeting the interleukin-5 pathway for treatment of eosinophilic conditions other than asthma","volume":"5","author":"Roufosse","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2024.07.018_bib20","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0161-5890(02)00013-5","article-title":"Cytokines and chemoattractants in allergic inflammation","volume":"38","author":"Romagnani","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2024.07.018_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2019.11.007","article-title":"Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study.","volume":"145","author":"Shoda","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.07.018_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fmed.2017.00261","article-title":"Eosinophilic Gastrointestinal Disorders Pathology.","volume":"4","author":"Collins","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2024.07.018_bib23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S2468-1253(23)00145-0","article-title":"Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"8","author":"Kliewer","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924007759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924007759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:16:47Z","timestamp":1730809007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674924007759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0091674924007759"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.07.018","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TH2 cell compensatory effect following benralizumab treatment for eosinophilic gastritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}